Earlier this year, biotech company 23andMe filed for bankruptcy. The harsh reality was that its business, while enticing to people who wanted to learn about their backgrounds via DNA testing kits, ...

U.S. senator wants to know how the FDA will enforce drug ad regulations after letting go numerous workers from the office ...

ORIC's Phase 1b trial of ORIC-944 in mCRPC shows PSA responses and strong tolerability, with Phase 3 trials and financing ...

FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...

The biotech is fighting to preserve its cash while continuing to push its key cancer treatment through clinical trials. HHS ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

East Midlands-based biotechnology company N4 Pharma has formed a new senior leadership team featuring consultants in drug ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or TG Therapeutics, Inc. is a better investment based on AAII's A+ ...

Indian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring ...